Scinovex
article Open AccessTop 10% cited

Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer

Breast Cancer Research and Treatment · 2007 · Vol. 108(2) · pp. 241–250
Keun Seok LeeHyun Cheol ChungSeock Ah ImWinnie YeoChul Soo KimSung‐Bae KimSun Young RhaMin Young LeeJungsil Ro
Cancer Treatment and PharmacologyHER2/EGFR in Cancer ResearchChemotherapy-related skin toxicityMedicineNeutropeniaMetastatic breast cancerInternal medicineChemotherapyBreast cancerGastroenterologyPremedicationPaclitaxelmyalgia
Citations
518
FWCI
6.90
field-weighted impact
References
34
Percentile
98%
vs. same field & year
Citations per year
Cited by
Imaging and drug delivery using theranostic nanoparticles
Advanced Drug Delivery Reviews · 2010 · 1,225 citations
Nanocarriers as an emerging platform for cancer therapy
Nature Nanotechnology · 2007 · 8,478 citations
Progress of drug-loaded polymeric micelles into clinical studies
Journal of Controlled Release · 2014 · 806 citations
Polylactic acid (PLA) controlled delivery carriers for biomedical applications
Advanced Drug Delivery Reviews · 2016 · 1,008 citations
EPR: Evidence and fallacy
Journal of Controlled Release · 2014 · 799 citations
Strategies in the design of nanoparticles for therapeutic applications
Nature Reviews Drug Discovery · 2010 · 3,576 citations
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Journal of Controlled Release · 2014 · 1,829 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.